BRCA1 and neoplasm: Contingency table analyses demonstrate significant differences in the EC tumor response rate between BRCA1-positive and BRCA1-negative baseline foci groups and between Rad51-positive and Rad51-negative EC-induced foci groups for all three criteria of the response rate (ZIO 65%, ZIO 50%, RECIST).